Xavier Matias-Guiu Guia
Degree: PhD
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Groups
Publications
-
MATIASGUIU, X; LaGuette, J; PurasGil, AM; Rosai, J
Metastatic neuroendocrine tumors to the thyroid gland mimicking medullary carcinoma: a pathologic and immunohistochemical study of six cases
AMERICAN JOURNAL OF SURGICAL PATHOLOGY 21 754-762. .
-
Berna, LI; Flotats, A; PuigDomingo, M; Piera, J; MATIASGUIU, X; Caixas, A; Estorch, M; Catafau, A; Mari, C; Carrio, I
Tc-99m-MIBI in the localization of parathyroid abnormal glands in patients presenting with primary hyperparathyroidism.
Journal Of Nuclear Medicine 38 609-609. .
-
Berna, LI; Mari, C; Chico, A; Piera, J; MATIASGUIU, X; Alonso, C; Flotats, A; Estorch, M; Catafau, A; Carrio, I
In-111-octreotide in the localization of recurrent medullary thyroid carcinoma.
Journal Of Nuclear Medicine 38 613-613. .
-
Cuatrecasas, M; Villanueva, A; MATIASGUIU, X; Prat, J
K-ras mutations in mucinous ovarian tumors - a clinicopathologic and molecular study of 95 cases
CANCER 79 1581-1586. .
[doi:10.1002/(SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO;2-T]
-
Garcia, A; MATIASGUIU, X; Cabezas, R; Chico, A; Prat, J; Baiget, M; DeLeiva, A
Molecular diagnosis of von Hippel-Lindau disease in a kindred with a predominance of familial phaeochromocytoma
CLINICAL ENDOCRINOLOGY 46 359-363. .
-
MATIASGUIU, X; Pons, C; Prat, J
Alpha-inhibin, mullerian inhibiting substance and CD 99 expression in functioning ovarian tumors.
LABORATORY INVESTIGATION 76 607-607. .
-
MATIASGUIU, X; Garcia, A; Cabezas, R; Chico, A; Baiget, M; DeLeiva, A; Prat, J
Molecular diagnosis of VonHippel-Lindau disease in familial pheochromocytoma
LABORATORY INVESTIGATION 76 280-280. .
-
MATIASGUIU, X; Lagarda, E; Calaf, M; Azpiroz, A; DeLeiva, A; Prat, J; Baiget, M
Identification of a novel somatic mutation in the RET proto oncogene in a patient with sporadic medullary thyroid carcinoma
HUM MUTAT 9 476-476. .
[doi:10.1002/(SICI)1098-1004(1997)9:5<476::AID-HUMU20>3.0.CO;2-Z]
-
MATIASGUIU, X; Villanueva, A; Cuatrecasas, M; Capella, G; DeLeiva, A; Prat, J
p53 in a thyroid follicular carcinoma with foci of poorly differentiated and anaplastic carcinoma
PATHOL RES PRACT 192 1242-1249. .
-
Fornas, O; Mato, ME; Viader, M; Oliver, B; Tresserres, P; Bartumeus, F; Tugues, D; Petriz, J; MATIASGUIU, X; Webb, SM
Flow cytometry analysis of pituitary adenomas
Hormone Research 46 257-262. .
-
Biarnes, J; Miranda, M; Corral, J; Gabau, E; MATIASGUIU, X; Matilla, A; Soler, J; Estivill, X; Volpini, V
The molecular pathology of RET protooncogen in families with multiple endocrine neoplasm type 2a
MEDICINA CLINICA 107 321-325. .
-
Domingo, P; Rodriguez, P; LopezContreras, J; Rebasa, P; Mota, S; MATIASGUIU, X
Spontaneous rupture of the spleen associated with pneumonia
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 15 733-736. .
Projects
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU